DELRAY BEACH, Fla., Oct. 28, 2025 /PRNewswire/ -- The global Cell-free Protein Synthesis Market, valued at US$203.9 million in 2024, stood at US$217.2 million in 2025 and is projected to advance at a ...

Oct 10 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab has decided to discontinue its cell therapy research and development efforts, a spokesperson for the Danish drugmaker told Reuters on Friday.

Novo Nordisk is ending all work in cell therapy, including a Type 1 diabetes program, amid CEO Maziar Mike Doustdar's reorganization. As part of the move, the company is laying off nearly all of the ...

The epidemiology of tumor lysis syndrome is evolving with the introduction of newer therapies. The occurrence of tumor lysis syndrome has become a less predictable but increasingly important aspect of ...

This is the online edition of The Wiretap newsletter, your weekly digest of cybersecurity, internet privacy and surveillance news. To get it in your inbox, subscribe here. ICE is using all manner of ...

Introduction Severe intraventricular haemorrhage (IVH) and white matter injury (WMI) are major neurological complications in preterm infants, leading to long-term neurodevelopmental impairments.

Platelet concentrates (PCs) have evolved from classical formulations to exosome-based therapies, reflecting a paradigm shift in regenerative medicine. This review analyzes three generations of PCs ...

Introduction Randomised controlled trials have aimed to assess the effectiveness of stereotactic ablative radiotherapy (SABR) with curative intent versus surgical resection for individuals diagnosed ...

Contributed by Cato T. Laurencin; received December 12, 2024; accepted May 13, 2025; reviewed by Edward A. Botchwey, Justin L. Brown, and Ali Khadamhoesseini ...